|
ZFP28 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
4.22680002110098E-10 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.129560E-01 |
| Stage1-vs-Stage3 |
1.60999999998523E-07 |
| Stage1-vs-Stage4 |
1.08049999947291E-07 |
| Stage2-vs-Stage3 |
9.696100E-02 |
| Stage2-vs-Stage4 |
4.615700E-02 |
| Stage3-vs-Stage4 |
5.607200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.437690E-04 |
| Normal-vs-Asian |
2.596200E-01 |
| Caucasian-vs-AfricanAmerican |
3.400100E-02 |
| Caucasian-vs-Asian |
1.159630E-01 |
| AfricanAmerican-vs-Asian |
7.800800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.422300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.06059999999786E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
7.105427357601E-15 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.422000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.197000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.487000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.079160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.312100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.500400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.679800E-02 |
| Normal-vs-Grade 2 |
1.64812608005604E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
<1E-12 |
| Grade 1-vs-Grade 2 |
2.063800E-01 |
| Grade 1-vs-Grade 3 |
5.85969999999936E-05 |
| Grade 1-vs-Grade 4 |
1.73497000000022E-05 |
| Grade 2-vs-Grade 3 |
2.39349995379001E-09 |
| Grade 2-vs-Grade 4 |
4.05809996717466E-09 |
| Grade 3-vs-Grade 4 |
1.473030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
4.235600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.62481139653892E-12 |
| N0-vs-N1 |
3.400400E-03 |
|
|
